Skip to main content
Sarilumab effective for polymyalgia rheumatica in phase 3 trial
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Sarilumab effective for polymyalgia rheumatica in phase 3 trial
User login
Username
Password
Reset your password
Specialty
Lead
score
Rheumatology
1
1
Family Medicine/Primary Care
0
0.9
Internal Medicine
0
0.8
Pharmacist
0
0.7
Concept
Lead
score
Glucocorticoid
0
0.98
Remission
0
0.99
Rheumatoid Arthritis
0
0.42
Biologic Therapy
0
0.41
Vasculitis
0
0.41
Polymyalgia Rheumatica
0
1
Quality of Life
0
0.23
Patient Safety
0
0.2
Sleep Disorders
0
0.2
Steroids
0
0.18
COVID-19
0
0.14
Diverticular Disease
0
0.14
Neutropenia
0
0.14
Scleroderma
0
0.14
Adherence
0
0.06
Adverse Effects
0
0.06
Arthralgia
0
0.06
Arthritis
0
0.06
C-Reactive Protein (CRP)
0
0.06
Disability
0
0.06
Disease-Modifying Antirheumatic Drugs
0
0.96
Diverticulitis
0
0.06
Geriatrics
0
0.06
Hospital
0
0.06
Insomnia
0
0.06
Interleukin
0
0.97
Myositis
0
0.06
New York
0
0.06
Pandemic
0
0.06
Receptors
0
0.06
Refractory
0
0.06
Surgery
0
0.06
Edit Tags